Nano Labs Isn't Selling Chips Anymore. It's a Leveraged Bet on BNB.

On August 28, Nano Labs (NA) reported its first half of 2026. The same week, it announced that director Nan Hu had tendered his resignation, effective today, August 31 — the company's standard line being that the departure is not expected to affect anything ongoing. A Form 144 filed the same week showed Hu planning to sell about 38,800 American depositary shares, roughly $82,000 worth, between September 1 and September 11.

A director leaving a $49 million company is a five-line announcement, and the $82,000 sale is pocket change. You could be forgiven for skipping both. This one is worth not skipping, but not because of the director. It is worth pausing on because of what the half-year report it bookends says the company has become.

Four years ago, in July 2022, Nano Labs listed on Nasdaq as a fabless chip designer building "high-throughput computing" chips and iPollo crypto-mining hardware. Its press releases today describe it as "a leading Web 3.0 infrastructure provider and crypto treasury company." That last phrase, "crypto treasury," is doing the real work. The financials explain exactly how much.

First-half revenue was RMB2.8 million, about US$0.4 million — down from RMB8.3 million a year earlier, a decline the company attributes to weaker sales of its iPollo V-series mining devices. Gross profit was negative. The company reported an operating loss of RMB291.7 million, but the bulk of it is one line: a RMB250.5 million loss from the change in the fair value of its cryptocurrency holdings, against a gain of RMB48.6 million on that same line a year earlier. Net loss was RMB316.7 million, about US$46.5 million, versus RMB11.8 million in the first half of 2025.

Do the compression yourself. Strip the products away and the rest of the profit-and-loss statement is, essentially, a marking exercise on coins. Consider that 2025 looked like a profitable year — the stock still carries a P/E of roughly 2.5 on 2025's earnings — even though the first half of 2025 lost RMB11.8 million. The full-year "profit" was booked almost entirely in the second half of 2025, exactly when BNB's price was peaking. Nothing about selling chips made this company money. The coin valuation did.

Then the pivot became explicit. In June 2025 Nano Labs announced a US$500 million convertible-note purchase agreement — interest-free, 360-day maturity, convertible into Class A ordinary shares at an initial price of US$20 — aimed at accumulating as much as US$1 billion of BNB. In July it bought roughly US$50 million of BNB (74,315 tokens at about US$672 apiece) in a single over-the-counter deal. The chip maker was becoming a coin accumulator, funded with debt that could one day become shares.

The balance sheet on June 30, 2026, is where the nature of the company shows itself. Total cryptocurrency assets were RMB368.8 million, about US$54 million — down from RMB768.6 million six months earlier as BNB fell in the first half of 2026. Against that stood roughly RMB223 million, about US$33 million, of borrowings, including RMB17.7 million denominated in cryptocurrency, plus loans carrying a stated long-term reserve of 70,000 BNB to back them. Cash was US$1.3 million. Total assets fell from about RMB1.1 billion to RMB736.7 million in six months — a near-pathological drop driven mostly by the coin mark. The mooted US$500 million note program was a ceiling, not the drawn amount; the books show a smaller debt stack than that. But the terms matter anyway: interest-free notes with a US$20 conversion price, against a stock trading around US$2.22 — repaid, rolled, or renegotiated on terms a prospective buyer should read in the footnotes. That is the detail this report can flag but not fully chase.

Step back from the mechanics and the picture is clear: the market prices Nano Labs's shares at US$48.85 million in market cap, about 0.86 times the US$56.8 million of book equity — and roughly half the balance sheet is coins. But the buyer who stops at "0.86 times book" also inherits the borrowings, the US$1.3 million of cash, the negative free cash flow of about US$15 million over the trailing year, and every other liability arrayed under and around the coin pile. Owning NA is a leveraged claim on BNB with a stack of extra risks the coin itself does not carry: the micro-cap structure, the daily 30% swings, the turnover near 150% of the listed float in a day, and a Nasdaq history that includes a delisting determination within days of its 2022 debut plus deficiency letters in 2024 tied to the US$15 million minimum market value of its publicly held shares. The stock is down about 30% year to date even after a 24% run over the last twenty days, and its 52-week range is US$1.58 to US$6.10.

Compare the template it is copying. Strategy (MSTR), the originator of the "borrow to buy digital assets" play, holds Bitcoin — an asset institutional lenders accept as collateral in a deep market — and trades at roughly 1.1 times book. Nano Labs holds BNB, an exchange token, at 0.86 times book, in a $49 million listing with daily double-digit volatility, backed partly by borrowed money. The discount to book is the market pricing in everything the coin chart doesn't show.

Now look at who is doing what, because behavior outranks labels. The chairman and CEO, Jianping Kong, has been buying: 1.1 million Class A shares in October 2024 and another 480,000 in August 2025, framed in company releases as confidence. The company runs a share-buyback program — US$25 million announced in late 2025, US$3.2 million completed as of late August. That is the person with the most to gain speaking with money. Alongside it, a departing director is selling a token position through a Rule 144 plan that starts the day after his resignation is effective. The buy-side signal and the sell-side signal here are both almost literally trivial in size, so don't over-read either. What matters is the pattern underneath: when the product stopped being bought, the company did not fix the product. It bought a balance sheet.

That is where a falsifiable test comes in. The only evidence that Nano Labs is really a business, rather than a treasury with a listing, is revenue. The hardware it launched this year — the March 2026 iPollo ClawPC A1 Mini, an appliance aimed at the AI-agent crowd, plus an April memorandum with ALT5 Sigma about North America data centers — has not shown up as meaningful, growing sales. First-half revenue fell by two-thirds. If those products convert into real revenue, there is a company underneath the coins, and the equity is worth more than the mark on a token. Until then, the honest reading is the reverse: revenue is the trailing indicator proving the label wrong, and the coin mark is the leading indicator that actually moves the stock.

So here is a simple discipline for anyone watching this name, drawn straight from the mechanics above. Watch one ratio each quarter: the carrying value of the cryptocurrency assets divided by total borrowings. On June 30 it was roughly 1.6. That number is the equity cushion between you and the coin price, and it tells you whether the company is spending its treasury to keep operating or holding it as a pure bet. Watch the revenue line for signs the operating business exists. And notice the general lesson hiding inside a boring headline: the director's resignation was never the news. The news is that a company can change what it is without changing its ticker — and that if you would not hold BNB on its own, owning a leveraged, thinly traded, $49 million version of it does not improve your odds. It adds a dumber version of the same bet.